
Bone Microvasculature: Stimulus for Tissue Function and Regeneration
Author(s) -
Eun Jin Lee,
Mahim Jain,
Stella Alimperti
Publication year - 2021
Publication title -
tissue engineering. part b, reviews/tissue engineering. part b, reviews.
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.579
H-Index - 91
eISSN - 1937-3376
pISSN - 1937-3368
DOI - 10.1089/ten.teb.2020.0154
Subject(s) - osteopetrosis , bone remodeling , regeneration (biology) , bone healing , medicine , bone remodeling period , homeostasis , bone tissue , pathology , osteoporosis , osteoclast , biology , microbiology and biotechnology , anatomy , receptor
Bone is a highly vascularized organ, providing structural support to the body, and its development, regeneration, and remodeling depend on the microvascular homeostasis. Loss or impairment of vascular function can develop diseases, such as large bone defects, avascular necrosis, osteoporosis, osteoarthritis, and osteopetrosis. In this review, we summarize how vasculature controls bone development and homeostasis in normal and disease cases. A better understanding of this process will facilitate the development of novel disease treatments that promote bone regeneration and remodeling. Specifically, approaches based on tissue engineering components, such as stem cells and growth factors, have demonstrated the capacity to induce bone microvasculature regeneration and mineralization. This knowledge will have relevant clinical implications for the treatment of bone disorders by developing novel pharmaceutical approaches and bone grafts. Finally, the tissue engineering approaches incorporating vascular components may widely be applied to treat other organ diseases by enhancing their regeneration capacity. Impact statement Bone vasculature is imperative in the process of bone development, regeneration, and remodeling. Alterations or disruption of the bone vasculature leads to loss of bone homeostasis and the development of bone diseases. In this study, we review the role of vasculature on bone diseases and how vascular tissue engineering strategies, with a detailed emphasis on the role of stem cells and growth factors, will contribute to bone therapeutics.